Tecnoglass Holdings Inc.
TGLSAbout the company
Tecnoglass Holdings Inc. manufactures, supplies, and installs architectural glass, windows, and aluminum and vinyl products for commercial and residential construction markets in Colombia, the United States, Panama, and internationally. The company offers low emissivity, laminated/thermo-laminated, thermo-acoustic, tempered, silk-screened, curved, and digital print glass products.
Investment snapshot
Positive
7
BUY / PASS
Neutral / negative
5 / 4
NEUTRAL / FAIL
Median fair value
$42.23
-9.6% vs price
Models with upside
4 / 17
Positive margin of safety
Strongest signal
5 of 8 pass — Lynch, Sleep and Neff object
Key risk
Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | NEUTRAL | FAIL | FAIL · Rank #977 (Top 31.5%) | PASS | NEUTRAL | NEUTRAL | BUY | PASS | FAIL | PASS | PASS | NEUTRAL | FAIL | PASS | NEUTRAL | FAIL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||
| Margin of Safety | -33.3% | -26.0% | +45.4% | -10.6% | N/A | +12.7% | -77.8% | +18.5% | +60.8% | -77.7% | -136.2% | -1.1% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | TTM ended 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-02 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-02 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-02 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-09 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-11-09 Score computed: 2026-11-14 |
Where It Passes
- Growth63% pass✓ 10✗ 3▾
5 of 8 pass — Lynch, Sleep and Neff object
EPS Growth (3-yr avg, 10-yr window)420.7%✓Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.30✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR45.7%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 41.4% vs Rev: 12.5%✗LynchInventory growth < Revenue growthEPS Growth Direction$0.29 (2012) -> $3.42 (2025)✓DremanPositive over recent yearsEPS CAGR20.9% CAGR over 13 years✓Dreman> 5% annualizedPositive Net Income Frequency13/14 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth10.5%✓Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR45.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 46.9% -> 42.8%, operating margin 31.2% -> 23.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR21.2%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR45.7% over 5 years✗Neff7%-20% annualized - Debt & Leverage58% pass✓ 9✗ 6▾
7 of 12 pass — Lynch, Piotroski, Akre +2 more object
Debt Levels0.36✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current AssetsLT Debt $287.1M vs NCA $355.3M✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.36, IC: 620.5x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.36✗Lynch< 0.33Cash - Long-term Debt$-189.4M✗LynchPositive preferredLT Debt / Total Assets Change10.64% -> 13.58%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.90✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.36✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=1.5x✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.36✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.3601; #2155/4210 (top 51.2%)✗AsnessTop 30% of eligible cross-section - Verdicts58% pass✓ 7✗ 5▾
Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY
Overall verdict✓GrahamPASS (4/9)•BuffettNEUTRAL (6/9)✗LynchFAIL (2/7)✗GreenblattRank #977✓PiotroskiPASS (F-Score 4)•DremanNEUTRAL (7/11)•MungerNEUTRAL (3/4)✓PabraiBUY (3/3)✓AkrePASS (3/6)✗MarksFAIL (3/5)✓AckmanPASS (5/9)✓TempletonPASS (4/8)•SleepNEUTRAL (4/6)✗AsnessFAIL (Rank #1076/2370 (Top 45.4%))✓NeffPASS (4/6)•SchlossNEUTRAL (5/7)✗OshaughnessyFAIL (Rank #286/963 (Top 29.7%))
Where It Falls Short
- Profitability25% pass✓ 17✗ 18▾
12 of 16 flag TGLS's profitability — Graham, Buffett, Lynch +9 more
Net income / market capitalization+4.79%; #1749/6340 (top 27.6%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)13/15 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)420.7%✓Graham>= 33% growthNet Income Positive (10+ years)13/15 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)30.8%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)23.5% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$140.3M✓BuffettPositive and growingEarnings Variance (10-yr CoV)1.03✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.30✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR45.7%✓Lynch15-30% (Fast Grower); > 0% to passROE12.2%✗Lynch> 15%EBIT / Enterprise Value7.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.0%, ROC=17.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets12.66%✓PiotroskiROA > 0ROA Change YoY15.87% -> 12.66% (delta: -3.21%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=10.77%, ROA=12.66%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY42.7% -> 42.8%✓PiotroskiImproved YoYPre-Tax Income / Revenue13.9%✓Dreman>= 8%Net Income / Shareholders' Equity12.2%✓Dreman> 12%Margin of SafetyP/E=13.7x, P/B=2.9x✓PabraiP/B < 1.5 or P/E < 15Return on Equity27.1% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value12.7% (IV=$53.50 vs Price=$46.69)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency13/14 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue14.4%✗Ackman>= 15%Net Income / Shareholders Equity12.2%✗Ackman>= 15%5-Year EPS CAGR45.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend31.2% (2023) -> 23.5% (2025)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 46.9% -> 42.8%, operating margin 31.2% -> 23.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+26.87%; #1599/3702 (top 43.2%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+12.17%; #1498/5226 (top 28.7%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0367; #2162/5884 (top 36.7%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR45.7% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation31% pass✓ 9✗ 19▾
9 of 13 flag TGLS's valuation — Graham, Greenblatt, Dreman +6 more
Net income / market capitalization+4.79%; #1749/6340 (top 27.6%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS13.1x✓Graham<= 15xPrice-to-Book Ratio2.9x✗Graham<= 1.5xP/E x P/B38.30✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.30✓Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value7.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.0%, ROC=17.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS13.7x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)15.4x✗Dreman< 8xPrice / Book Value per Share2.9x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=13.7x, OE Yield=4.6%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=13.7x, FCF Yield=1.7%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=13.7x, P/B=2.9x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value12.7% (IV=$53.50 vs Price=$46.69)✗Marks>= 20% below intrinsic valuePrice / FCF per Share60.6x✗Ackman<= 25Price vs. Trailing Low134% of trailing low ($34.75)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.3936; #3306/6449 (top 51.3%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS13.7x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E3.45✓Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share3.12x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+265.4%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.5311; #2553/5247 (top 48.7%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-3.60%; #2870/4519 (top 63.5%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+7.11%; #2022/6202 (top 32.6%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models36% pass✓ 4✗ 7▾
Models split on TGLS at $46.69 — fair values range $19.77–$118.99
Graham fair value$35.02✗Graham-33.3% margin vs $46.69Buffett fair value$37.06✗Buffett-26.0% margin vs $46.69Lynch fair value$85.50✓Lynch+45.4% margin vs $46.69Greenblatt fair value$42.23✗Greenblatt-10.6% margin vs $46.69Dreman fair value$53.50✓Dreman+12.7% margin vs $46.69Munger fair value$26.26✗Munger-77.8% margin vs $46.69Pabrai fair value$57.30✓Pabrai+18.5% margin vs $46.69Akre fair value$118.99✓Akre+60.8% margin vs $46.69Marks fair value$26.27✗Marks-77.7% margin vs $46.69Ackman fair value$19.77✗Ackman-136.2% margin vs $46.69Templeton fair value$46.20✗Templeton-1.1% margin vs $46.69 - Efficiency38% pass✓ 5✗ 6▾
5 of 8 flag TGLS's efficiency — Graham, Greenblatt, Piotroski +2 more
Current Ratio1.90✗Graham>= 2.0ROIC (3-5 yr avg)31.3%✓Buffett> 10%ROIC - WACC+21.3%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)17.6%✗Greenblatt> 25%Current Ratio Change YoY2.11 -> 1.86✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.88x -> 0.78x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.90✓Dreman> 1.5Return on Invested Capital11.3%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=28.6%; FY2024: ROIC=24.2%; FY2025: ROIC=20.6%✓AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC8.2% (RR=73% x ROIC=11.3%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)5/5 years above 12% (latest 20.6%)✓SleepROIC > 12% in a majority of years - Cash Flow40% pass✓ 5✗ 7▾
6 of 10 flag TGLS's cash flow — Lynch, Piotroski, Dreman +3 more
Free Cash Flow Proxy$140.3M✓BuffettPositive and growingFCF Positive and Growing$-74.6M✗LynchPositive and growingOperating Cash Flow$135.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=10.77%, ROA=12.66%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)15.4x✗Dreman< 8xP/E or FCF YieldP/E=13.7x, FCF Yield=1.7%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive8/14 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-3.6%✗Ackman>= 4%Price / FCF per Share60.6x✗Ackman<= 25Positive Operating Cash Flow frequency10/14 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-74.6M✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-3.60%; #2870/4519 (top 63.5%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 4.8% of shares last year, 4.8% over two.
- Buybacks
- $118.0M
- Dividends
- $28.1M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.1Bcurrent | -- | -- | -- | $2.2Best. | $3.5Best. | $2.1Best. | $1.6Best. | $947.3Mest. |
| Revenue | $1.1B↑13% | $310.6M↑19% | $295.3M↑16% | $249.0M↑12% | $983.6M↑10% | $890.2M↑7% | $833.3M↑16% | $716.6M↑44% | $496.8M |
| Operating Income | $158.2M↓37% | $31.9M↓51% | $36.5M↓40% | $44.9M↓24% | $230.7M↑2% | $227.0M↓13% | $259.8M↑15% | $226.4M↑94% | $117.0M |
| Net Income | $99.3M↓45% | $16.7M↓65% | $24.6M↓44% | $31.9M↓24% | $159.6M↓1% | $161.3M↓12% | $182.9M↑17% | $155.7M↑129% | $68.2M |
| EPS (Diluted) | -- | $0.38↓62% | $0.55↓41% | $0.71↓21% | $3.42 | $3.43↓11% | $3.85↑17% | $3.28↑129% | $1.43 |
| Gross Margin | 37.3%↓15% | 34.1%↓20% | 37.3%↓17% | 38.5%↓12% | 42.8% | 42.7%↓9% | 46.9%↓4% | 48.8%↑20% | 40.8% |
| Operating Margin | 14.4%↓44% | 10.3%↓59% | 12.4%↓48% | 18.0%↓32% | 23.5%↓8% | 25.5%↓18% | 31.2%↓1% | 31.6%↑34% | 23.5% |
| ROE | 12.2%↓48% | — | — | — | 22.4%↓12% | 25.6%↓23% | 33.4%↓25% | 44.6%↑60% | 27.9% |
| Total Debt | $293.6M↑162% | $293.6M↑162% | $225.4M↑106% | $200.3M↑84% | $171.6M↑57% | $109.3M↓36% | $170.0M | $169.5M↓15% | $199.1M |
| Shareholders' Equity | $815.4M↑7% | $815.4M↑7% | $788.8M↑7% | $735.2M↑7% | $713.1M↑13% | $631.2M↑15% | $548.0M↑57% | $348.8M↑43% | $243.9M |
| Current Ratio | 1.90↓4% | 1.90↓4% | 1.86↓7% | 1.77↓8% | 1.86↓12% | 2.11↓7% | 2.27↑10% | 2.06↓2% | 2.10 |
| Debt / Equity | 0.36↑146% | 0.36↑146% | 0.29↑93% | 0.27↑71% | 0.24↑39% | 0.17↓44% | 0.31↓36% | 0.49↓40% | 0.82 |
| Operating Cash Flow | $63.6M↓62% | $21.5M↓46% | $4.4M↓75% | $6.7M↓86% | $135.8M↓20% | $170.5M↑23% | $138.8M↓2% | $141.9M↑21% | $117.3M |
| Free Cash Flow | -$74.6M↓228% | -$44.5M↓310% | -$31.0M↓112% | -$10.5M↓164% | $34.5M↓62% | $91.0M↑49% | $60.9M↓14% | $70.6M↑7% | $65.7M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Construction Materials
TGLS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRH PUBLIC LTD COCRH | $62.0B | $93.16 | $37.4B | $3.8B | 15.6% | 0.74 | 14.5% | 1.74 | 1/9 | 5/9 | 2/7 | 0/3 | F-Score 6 | 4/11 |
| Snap-on IncSNA | $19.0B | $368.62 | $5.2B | $1.0B | 17.1% | 0.20 | 25.8% | 4.79 | 6/9 | 6/9 | 4/7 | 1/3 | F-Score 6 | 7/11 |
| MASCO CORP /DE/MAS | $16.3B | $84.68 | $7.6B | $810.0M | -437.8% | -15.93 | 16.5% | 1.81 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 6 | 5/11 |
| CEMEX SAB DE CVCX | $15.2B | $10.55 | $16.2B | $939.0M | 7.7% | 0.44 | 11.2% | 0.82 | 2/9 | 1/9 | 2/7 | 0/3 | F-Score 8 | 4/11 |
| VALMONT INDUSTRIES INCVMI | $8.1B | $420.92 | $4.1B | $350.3M | 21.5% | 0.49 | 10.1% | 2.35 | 4/9 | 7/9 | 2/7 | 1/3 | F-Score 5 | 5/11 |
| Simpson Manufacturing Co., Inc.SSD | $8.0B | $198.01 | $2.3B | $345.1M | 17.0% | 0.15 | 19.6% | 3.54 | 5/9 | 6/9 | 6/7 | 1/3 | F-Score 6 | 5/11 |
| Arcosa, Inc.ACA | $7.3B | $149.03 | $2.9B | $208.4M | 7.9% | 0.58 | 11.9% | 2.20 | 3/9 | 2/9 | 3/7 | 0/3 | F-Score 8 | 7/11 |
| Fortune Brands Innovations, Inc.FBIN | $5.7B | $48.05 | $4.5B | $298.8M | 12.5% | 1.07 | 11.6% | 1.84 | 2/9 | 4/9 | 1/7 | 0/3 | F-Score 5 | 4/11 |